4.0
Aug 28, 2022
Current employee
Cambridge, MA
Recommend
CEO approval
Business Outlook
Pros
Excellent science and nice community of people.
Cons
Low work-life balance, stretched resource across projects. Lower compensation relative to other big pharma/biotech.